No Detail Found!

Evaluation of New Formulation (Verona X Tablet) in Patients with Erectile Dysfunction.

Author(s)
Zubair Ali Department of Medical Afairs and Training, Herbion Pharmaceutical (Pvt.) Limited Karachi, Pakistan
Majid Ali Khan Memon medical complex, Karachi Pakistan
Shamsheer Ali Khan Khyber Medical Center, Karachi, Pakistan
Muhammad Daniyal Department of Medical Afairs and Training, Herbion Pharmaceutical (Pvt.) Limited Karachi, Pakistan
Abstract
Introduction: Erectile dysfunction (ED)is highly prevalent aefcting almost 50% of men in the 40-70 year age range especially in those who have co-morbidities like diabetes, atherosclerosis, hypertension etc. Over recent years, the use of complementary and alternative medicines has become increasingly popular, and ED is one condition for which herbal supplements are heavily promoted and easily accessible. Traditional herbs have been a revolutionary breakthrough in the management of ED and have become known worldwide as 'instant' treatment. Major progress has been made in this field and at present a number of herbs are identified as a sexual stimulator. This knowledge has led to the discovery of several new therapeutic targets and multiple medical approaches for the treatment of erectile dysfunction (ED). This research focuses on the combination of selected herb in the treatment of ED. Aim: To examine the eefcts of Verona X tablet therapy on ED using the five-item version of the International Inventory of Erectile Function (IIEF). Methods: In this multicenter, phase 2 trial, we collect 38 Subjects from diefrent hospitals to receive Verona X tablet a 4-weeks treatment period. Subjects were instructed to take study drug twice a day; no restrictions were placed on food or alcohol intake. On 2nd and 4th weeks we take follow up and record the results. Main Outcome Measures: Improvement in erectile function (EF) was measured by International Index of Erectile Function (IIEF) questionnaire. Results:38 patients were selected for the multicenter clinical trial. Out of 38 patient 36 patients documented the improvement in ED. At the follow-up endpoint, Verona X tablet found to be eefctive and the tolerability was good. No adverse events were reported during the study period. Conclusion: The results from the current meta-analysis have suggested that Verona X is an eefctive and well-tolerated therapy for erectile dysfunction. The findings of the present research highlight the need for more eficient performance of higher quality, largesample, various-race, long-term, randomized controlled trials to verify the efficacy and safety of Verona X tablet.
Publication Details
Page(s) 141-145
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 4, Issue: 1, Year: 2016

Request the full text from PASTIC

Keywords
premature ejaculation, Herbal medicine, Erectile dysfunction, Verona X tablet
References
LewisRW,Fugl-MeyerKS,BoschR,Fugl-MeyerAR,LaumannEO,LizzaE, 2004.Epidemiology/risk factors of sexual dysfunction,J Sex Med 1 35 -39
BerookhimBM,Bar-Chama N, 2011.Medical implications of erectile dysfunction,MedClin North Am 95 213 -221
MesquitaJF,RamosTF,MesquitaFP,BastosNettoJM,BastosMG,FigueiredoAA, 2012.Prevalence of erectile dysfunction in chronic renal disease patients on conservative treatment,Clinics (Sao Paulo) 67 181 -3
GlinaS,SharlipID, 2012.HellstromWJ. Modifying risk factors to prevent and treat erectile dysfunction,J Sex Med 10 115 -9
ShamloulR,GhanemH, 2013.Erectile dysfunction,Lancet 381 153 -65
ChungE,BrockGB, 2011.Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction,CurrUrol Rep 12 432 -43
FeldmanHA,GoldsteinI,HatzichristouDG,KraneRJ,McKinlayJB, 1994.Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study,J Urol 151 54 -61
AytaIA,McKinlayJB,KraneRJ, 1999.eTh likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences,BJU Int 84 50 -6
JacksonG, 2006.Erectile dysfunction: A marker of silent coronary artery disease,Eur Heart J 27 2613 -4
MontorsiP,RavagnaniPM,GalliS,RotatoriF,VegliaF,BrigantiA,SaloniaA, ., -
GandagliaG,SaloniaA,PassoniN,MontorsiP,BrigantiA,MontorsiF, 2013.Erectile dysfunction as a cardiovascular risk factor in patients with diabetes,Endocrine 43 285 -92
RyanJG,GajrajJ, 2012.Erectile dysfunction and its association with metabolic syndrome and endothelial function among patients with type 2 diabetes mellitus,J Diabetes Complications 26 141 -7
IsmailSB,Wan MohammadWM,GeorgeA,NikHussainNH, 2012.Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried WaterExtract of EurycomaLongifolia for the Improvement of Quality of Life and Sexual Well-being in Men,Evidence-based Complementary and Alternative Medicine 429268 -
LowWY,WongYL,ZulkifliSN,TanHM, 2002.Malaysian cultural diefrences inknowledge, attitudes and practices related to erectile dysfunction: focusgroup discussions,Int J Impot Res 14 440 -445
TanHM,LowWY,NgCJ,ChenKK,SugitaM,IshiiN, 2007.Prevalence andcorrelates of erectile dysfunction (ED) and treatment seeking for ED in Asianmen: the Asian men's attitudes to life events and sexuality (males) study,J SexMed 4 6 -1592
AlbersenM,ShindelAW,MwamukondaKB,LueTF, 2010b.eTh future is today: emerging drugs for the treatment of erectile dysfunction,Expert OpinEmerg Drugs 15 467 -80
AnderssonKE, 2011.Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction,Pharmacol Rev 63 811 -59
BurnettAL,GoldsteinI,AnderssonKE,ArgiolasA,ChristG,ParkK, 2010.Future sexual medicine physiological treatment targets,J Sex Med 7 3269 -304
DecaluweK,PauwelsB,VerpoestS, 2011.New therapeutic targets for the treatment of erectile dysfunction,J Sex Med 8 3271 -90
FeiferA,CarrierS, 2008.Pharmacotherapy for erectile dysfunction,Expert OpinInvestig Drugs 17 679 -90
2008.Looking to the future for erectile dysfunction therapies,Drugs 68 231 -50
WilliamsSK,MelmanA, 2012.Novel therapeutic targets for erectile dysfunction,Maturitas 71 20 -7
0

Citations

0

Downloads

48

Views